Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsReceivables - Other
Ratios

Dare Bioscience (DARE) Leases (2020 - 2025)

Dare Bioscience (DARE) has disclosed Leases for 6 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases rose 72.62% year-over-year to $2.2 million, compared with a TTM value of $2.2 million through Sep 2025, up 72.62%, and an annual FY2024 reading of $1.2 million, down 8.54% over the prior year.
  • Leases was $2.2 million for Q3 2025 at Dare Bioscience, up from $955651.0 in the prior quarter.
  • Across five years, Leases topped out at $3.1 million in Q1 2025 and bottomed at $216700.0 in Q4 2021.
  • Average Leases over 5 years is $1.4 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Leases surged 188.18% in 2023, then plummeted 31.74% in 2025.
  • Year by year, Leases stood at $216700.0 in 2021, then soared by 111.32% to $457925.0 in 2022, then soared by 188.18% to $1.3 million in 2023, then fell by 8.54% to $1.2 million in 2024, then surged by 85.93% to $2.2 million in 2025.
  • Business Quant data shows Leases for DARE at $2.2 million in Q3 2025, $955651.0 in Q2 2025, and $3.1 million in Q1 2025.